Screener
Organon OGN Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Organon in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Organon’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 8:46 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-029532
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Accrued and other current liabilities | 95 | 39 |
| Income taxes payable | (4) | 38 |
| Other | 8 | 40 |
| Net Cash Flows Provided by Operating Activities | 225 | 75 |
| Cash Flows from Investing Activities | ||
| Capital expenditures | (37) | (32) |
| Acquired in-process research and development and milestones | (10) | (10) |
| Proceeds from sale of Jada | 433 | — |
Item 1. Financial Statements (unaudited)
FAQ
- What is Organon's operating cash flow?
- Organon (OGN) reported operating cash flow of $225M in Q1 2026.
- How has Organon's operating cash flow changed year-over-year?
- Organon's operating cash flow increased by 200.0% year-over-year, from $75M to $225M.
- What is the long-term trend for Organon's operating cash flow?
- Over 4 years (2021 to 2025), Organon's operating cash flow has grown at a -24.5% compound annual growth rate (CAGR), from $2.16B to $700M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Organon's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude